Muramyl Dipeptide and its Derivatives: Peptide Adjuvant in Immunological Disorders and Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6646|7|3|180-197

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.7, Iss.3, 2011-09, pp. : 180-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant medical therapy for prostate cancer

By Sumey Christopher   Flaig Thomas W  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 73-84

Informa Healthcare

Access to resources Recommend Favorite

Aminoglutethimide adjuvant therapy in breast cancer

By  

Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Adjuvant Therapy for Rectal Cancer in the Elderly

By Cohen S.M.   Neugut A.I.  

Drugs & Aging, Vol. 21, Iss. 7, 2004-01 ,pp. : 437-451

Adis International

Access to resources Recommend Favorite

The role of adjuvant therapy for pancreatic cancer

By Hartley Mark   Ghaneh Paula   Sutton Robert   Neoptolemos John P   Magee Conor J  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 1, 2001-01 ,pp. : 87-107

Informa Healthcare

Access to resources Recommend Favorite

Epirubicin: A Review of its Efficacy as Adjuvant Therapy and in the Treatment of Metastatic Disease in Breast Cancer

By Ormrod D.   Holm K.   Goa K.   Spencer C.  

Drugs & Aging, Vol. 15, Iss. 5, 1999-11 ,pp. : 389-416

Adis International

Access to resources Recommend Favorite